3.21
+0.17(+5.59%)
Currency In USD
| Previous Close | 3.04 |
| Open | 2.98 |
| Day High | 3.34 |
| Day Low | 2.86 |
| 52-Week High | 8.81 |
| 52-Week Low | 1.61 |
| Volume | 368,768 |
| Average Volume | 2.65M |
| Market Cap | 5.43M |
| PE | 1.13 |
| EPS | 2.85 |
| Moving Average 50 Days | 3.63 |
| Moving Average 200 Days | 3.2 |
| Change | 0.17 |
Data not available
Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy
GlobeNewswire Inc.
Nov 16, 2025 9:10 PM GMT
Shareholders approved all proposals, confirming Faraday Future Intelligent Electric Inc. (“Faraday Future”) as the Company’s new majority and controlling shareholder.Faraday Future will nominate a majority of board seats prior to November 20 as part
Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025
GlobeNewswire Inc.
Oct 28, 2025 3:57 AM GMT
Dubai, UAE / Beijing, China, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ: QLGN) (“Qualigen”, “QLGN” or the “Company”), a publicly-traded technology company majority owned by Faraday Future Intelligent Electric Inc. (NASDAQ:
Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation
GlobeNewswire Inc.
Oct 23, 2025 8:05 PM GMT
New York, NY, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ: QLGN) (“Qualigen”, “QLGN” or “Company”), a publicly-trading technology company majority owned by Faraday Future, today announced a strategic partnership with BitGo,